156 related articles for article (PubMed ID: 21612925)
21. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
22. [The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS].
Cao X; You QD; Li ZY; Guo QL; Yang Y; Shang J; Yan M; Chen JW; Chen ML
Yao Xue Xue Bao; 2009 Mar; 44(3):288-95. PubMed ID: 19449526
[TBL] [Abstract][Full Text] [Related]
23. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
25. Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.
Fallah-Tafti A; Foroumadi A; Tiwari R; Shirazi AN; Hangauer DG; Bu Y; Akbarzadeh T; Parang K; Shafiee A
Eur J Med Chem; 2011 Oct; 46(10):4853-8. PubMed ID: 21852023
[TBL] [Abstract][Full Text] [Related]
26. A facile route to polysubstituted indoles via three-component reaction of 2-ethynylaniline, sulfonyl azide, and nitroolefin.
Chen Z; Zheng D; Wu J
Org Lett; 2011 Mar; 13(5):848-51. PubMed ID: 21299243
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents.
Kassis P; Brzeszcz J; Bénéteau V; Lozach O; Meijer L; Le Guével R; Guillouzo C; Lewiński K; Bourg S; Colliandre L; Routier S; Mérour JY
Eur J Med Chem; 2011 Nov; 46(11):5416-34. PubMed ID: 21944287
[TBL] [Abstract][Full Text] [Related]
28. Novel DNA intercalators without basic side chains as efficient antitumor agents: design, synthesis and evaluation of benzo-[c,d]-indol-malononitrile derivatives.
Li X; Wang Q; Qing Y; Lin Y; Zhang Y; Qian X; Cui J
Bioorg Med Chem; 2010 May; 18(9):3279-84. PubMed ID: 20385497
[TBL] [Abstract][Full Text] [Related]
29. Dual IGF-1R/SRC inhibitors based on a N'-aroyl-2-(1H-indol-3-yl)-2-oxoacetohydrazide structure.
Schmidt S; Preu L; Lemcke T; Totzke F; Schächtele C; Kubbutat MH; Kunick C
Eur J Med Chem; 2011 Jul; 46(7):2759-69. PubMed ID: 21524503
[TBL] [Abstract][Full Text] [Related]
30. Oriented synthesis and in vitro anticancer activity of biquinazoline-2,2'-diones.
Dou G; Shi D; Li Y
J Comb Chem; 2010; 12(1):195-9. PubMed ID: 20028094
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of new heteroaryl and heteroannulated indoles from dehydrophenylalanines: Antitumor evaluation.
Queiroz MJ; Abreu AS; Carvalho MS; Ferreira PM; Nazareth N; São-José Nascimento M
Bioorg Med Chem; 2008 May; 16(10):5584-9. PubMed ID: 18439831
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro and in vivo anticancer activity of novel 3-methyl-5H-isoxazolo[5',4':5,6]pyrido[2,3-b]indoles.
Rajanarendar E; Govardhan Reddy K; Ramakrishna S; Nagi Reddy M; Shireesha B; Durgaiah G; Reddy YN
Bioorg Med Chem Lett; 2012 Nov; 22(21):6677-80. PubMed ID: 23031598
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.
Fortes MP; da Silva PB; da Silva TG; Kaufman TS; Militão GC; Silveira CC
Eur J Med Chem; 2016 Aug; 118():21-6. PubMed ID: 27116711
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles.
Boschelli DH; Wu B; Barrios Sosa AC; Durutlic H; Chen JJ; Wang Y; Golas JM; Lucas J; Boschelli F
J Med Chem; 2005 Jun; 48(11):3891-902. PubMed ID: 15916442
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
Olgen S; Akaho E; Nebioglu D
Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
[TBL] [Abstract][Full Text] [Related]
37. Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs.
Choi T; Ma E
Arch Pharm Res; 2011 Mar; 34(3):357-67. PubMed ID: 21547666
[TBL] [Abstract][Full Text] [Related]
38. Sulfamic acid promoted one-pot three-component synthesis and cytotoxic evaluation of spirooxindoles.
Kamal A; Babu KS; Vishnu Vardhan MV; Hussaini SM; Mahesh R; Shaik SP; Alarifi A
Bioorg Med Chem Lett; 2015; 25(10):2199-202. PubMed ID: 25870131
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
40. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles.
Kumar D; Kumar NM; Sundaree S; Johnson EO; Shah K
Eur J Med Chem; 2010 Mar; 45(3):1244-9. PubMed ID: 20047778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
